Skip to main content
. Author manuscript; available in PMC: 2006 Oct 2.
Published in final edited form as: Biochemistry. 2004 Jul 20;43(28):9234–9242. doi: 10.1021/bi049468v

Figure 3. Differential activation of purified seHAS by different cardiolipin preparations.

Figure 3

Recombinant seHAS was purified in the absence of phospholipids and then assayed in the presence of increasing amounts (0–2 mM) of commercial cardiolipin mixtures prepared by extraction from bovine heart (•) or E. coli membranes, (▪) or synthetic cardiolipin preparations containing only myristic (▴) or oleic (♦) fatty acids.